GUIDELINES FOR GENERAL-PRACTITIONERS ADMINISTERING THROMBOLYTICS

被引:9
作者
RAWLES, J
机构
[1] Medicines Assessment Research Unit, University of Aberdeen, Aberdeen, AB9 2ZD, Foresterhill
关键词
D O I
10.2165/00003495-199550040-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Acute myocardial infarction (AMT) recognises no boundaries, and the patient's greatest need occurs at the interface between primary care and the hospital system. Ideally, the general practitioner, if summoned, should be able to provide resuscitation, analgesia with opiates, and thrombolytic therapy. Thrombolytics should certainly be given to eligible patients by the general practitioner if an hour could be saved by so doing. Optimising the risk-benefit ratio for thrombolytic therapy given in the community is a challenge to clinical judgement. Experience with this potent treatment is best obtained under a degree of supervision, which could take the form of an audit of the prehospital management of suspected AMI. With prehospital administration of thrombolytic therapy at the first opportunity, the chances of saving a life are better than 1 in 10, while the excess risk of a disabling stroke is about 1 in 1000.
引用
收藏
页码:615 / 625
页数:11
相关论文
共 45 条
  • [1] EARLIEST ELECTROCARDIOGRAPHIC EVIDENCE OF MYOCARDIAL-INFARCTION - IMPLICATIONS FOR THROMBOLYTIC TREATMENT
    ADAMS, J
    TRENT, R
    RAWLES, J
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1993, 307 (6901): : 409 - 413
  • [2] [Anonymous], 1990, LANCET, V336, P65
  • [3] [Anonymous], 1988, LANCET, V2, P349
  • [4] [Anonymous], 1986, LANCET, V1, P397
  • [5] [Anonymous], 1993, Lancet, V342, P767
  • [6] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
    APPLEBY, P
    BAIGENT, C
    COLLINS, R
    FLATHER, M
    PARISH, S
    PETO, R
    BELL, P
    HALLS, H
    MEAD, G
    DIAZ, R
    PAOLASSO, E
    PAVIOTTI, C
    ROMERO, G
    CAMPBELL, T
    OROURKE, MF
    THOMPSON, P
    LESAFFRE, E
    VANDEWERF, F
    VERSTRAETE, M
    ARMSTRONG, PW
    CAIRNS, JA
    MORAN, C
    TURPIE, AG
    YUSUF, S
    GRANDE, P
    HEIKKILA, J
    KALA, R
    BASSAND, JP
    BOISSEL, JP
    BROCHIER, M
    LEIZOROVICZ, A
    BRUGGEMANN, T
    KARSCH, KR
    KASPER, W
    LAMMERTS, D
    NEUHAUS, KL
    MEYER, J
    SCHRODER, R
    VONESSEN, R
    SARAN, RK
    ARDISSINO, D
    BONADUCE, D
    BRUNELLI, C
    CERNIGLIARO, C
    FORESTI, A
    FRANZOSI, MG
    GUIDUCCI, D
    MAGGIONI, A
    MAGNANI, B
    MATTIOLI, G
    [J]. LANCET, 1994, 343 (8893) : 311 - 322
  • [7] ARMSTRONG A, 1972, BRIT HEART J, V34, P67
  • [8] TIME DELAYS IN PROVISION OF THROMBOLYTIC TREATMENT IN 6 DISTRICT HOSPITALS
    BIRKHEAD, JS
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6851): : 445 - 448
  • [9] EFFECTS OF LATE ADMINISTRATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR ON LEFT-VENTRICULAR REMODELING AND FUNCTION AFTER MYOCARDIAL-INFARCTION
    BONADUCE, D
    PETRETTA, M
    VILLARI, B
    BREGLIO, R
    CONFORTI, G
    MONTEMURRO, MV
    LANZILLO, T
    MORGANO, G
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (07) : 1561 - 1568
  • [10] REDUCTION IN INCIDENCE OF INDUCIBLE VENTRICULAR-TACHYCARDIA AFTER MYOCARDIAL-INFARCTION BY TREATMENT WITH STREPTOKINASE DURING INFARCT EVOLUTION
    BOURKE, JP
    YOUNG, AA
    RICHARDS, DAB
    UTHER, JB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (07) : 1703 - 1710